Long-Term Treatment with Fluvoxamine Decreases Nonmotor Symptoms and Dopamine Depletion in a Postnatal Stress Rat Model of Parkinson's Disease

Nonmotor symptoms (NMS) such as anxiety, depression, and cognitive deficits are frequently observed in Parkinson's disease (PD) and precede the onset of motor symptoms by years. We have recently explored the short-term effects of Fluvoxamine, a selective serotonin reuptake inhibitor (SSRI) on d...

Descripción completa

Detalles Bibliográficos
Autores principales: Dallé, Ernest, Daniels, William M. U., Mabandla, Musa V.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Hindawi 2020
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7114775/
https://www.ncbi.nlm.nih.gov/pubmed/32273939
http://dx.doi.org/10.1155/2020/1941480

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7114775/
https://www.ncbi.nlm.nih.gov/pubmed/32273939
http://dx.doi.org/10.1155/2020/1941480

Ejemplares similares